602 related articles for article (PubMed ID: 23429702)
21. A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity.
Shie JJ; Fang JM; Lai PT; Wen WH; Wang SY; Cheng YS; Tsai KC; Yang AS; Wong CH
J Am Chem Soc; 2011 Nov; 133(44):17959-65. PubMed ID: 21942552
[TBL] [Abstract][Full Text] [Related]
22. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 6-acetamido-5-amino- and -5-guanidino-3, 4-dehydro-N-(2-ethylbutyryl)- 3-piperidinecarboxylic acids related to zanamivir and oseltamivir, inhibitors of influenza virus neuraminidases.
Shitara E; Nishimura Y; Nerome K; Hiramoto Y; Takeuchi T
Org Lett; 2000 Nov; 2(24):3837-40. PubMed ID: 11101432
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun C; Zhang X; Huang H; Zhou P
Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
[TBL] [Abstract][Full Text] [Related]
25. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY; Hayden FG
Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
[No Abstract] [Full Text] [Related]
26. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
[TBL] [Abstract][Full Text] [Related]
27. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
Magano J
Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
[No Abstract] [Full Text] [Related]
28. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
[TBL] [Abstract][Full Text] [Related]
29. Neuraminidase inhibitors as anti-influenza virus agents.
Kim CU; Chen X; Mendel DB
Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
[TBL] [Abstract][Full Text] [Related]
30. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
31. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
[TBL] [Abstract][Full Text] [Related]
32. A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.
Sriwilaijaroen N; Magesh S; Imamura A; Ando H; Ishida H; Sakai M; Ishitsubo E; Hori T; Moriya S; Ishikawa T; Kuwata K; Odagiri T; Tashiro M; Hiramatsu H; Tsukamoto K; Miyagi T; Tokiwa H; Kiso M; Suzuki Y
J Med Chem; 2016 May; 59(10):4563-77. PubMed ID: 27095056
[TBL] [Abstract][Full Text] [Related]
33. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
Stanley M; Martin SR; Birge M; Carbain B; Streicher H
Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
[TBL] [Abstract][Full Text] [Related]
34. [Research progress of neuraminidase inhibitors for anti-influenza].
Liu AL; Wang HD; Yang F; Du GH
Yao Xue Xue Bao; 2009 Sep; 44(9):935-42. PubMed ID: 20055166
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.
Hatakeyama S; Sakai-Tagawa Y; Kiso M; Goto H; Kawakami C; Mitamura K; Sugaya N; Suzuki Y; Kawaoka Y
J Clin Microbiol; 2005 Aug; 43(8):4139-46. PubMed ID: 16081961
[TBL] [Abstract][Full Text] [Related]
36. Antiviral drugs for influenza 2012-2013.
Med Lett Drugs Ther; 2012 Dec; 54(1405):97-8. PubMed ID: 23223245
[No Abstract] [Full Text] [Related]
37. Inhibitors targeting the influenza virus hemagglutinin.
Li F; Ma C; Wang J
Curr Med Chem; 2015; 22(11):1361-82. PubMed ID: 25723505
[TBL] [Abstract][Full Text] [Related]
38. Tamiphosphor monoesters as effective anti-influenza agents.
Chen CL; Lin TC; Wang SY; Shie JJ; Tsai KC; Cheng YS; Jan JT; Lin CJ; Fang JM; Wong CH
Eur J Med Chem; 2014 Jun; 81():106-18. PubMed ID: 24836064
[TBL] [Abstract][Full Text] [Related]
39. Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
Mai BK; Li MS
Biochem Biophys Res Commun; 2011 Jul; 410(3):688-91. PubMed ID: 21693105
[TBL] [Abstract][Full Text] [Related]
40. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor.
Lew W; Chen X; Kim CU
Curr Med Chem; 2000 Jun; 7(6):663-72. PubMed ID: 10702632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
